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Abstract
Background: Integrin-linked kinase (ILK) is a multifunctional adaptor protein which is involved with protein signalling
within cells to modulate malignant (cancer) cell movement, cell cycle, metastasis and epithelial–mesenchymal
transition (EMT). Our previous experiment demonstrated that ILK siRNA inhibited the growth and induced apoptosis of
bladder cancer cells as well as increased the expression of Ribonuclease inhibitor (RI), an important cytoplasmic protein
with many functions. We also reported that RI overexpression inhibited ILK and phosphorylation of AKT and GSK3β. ILK
and RI gene both locate on chromosome 11p15 and the two genes are always at the adjacent position of same
chromosome during evolution, which suggest that ILK and RI could have some relationship. However, underlying
interacting mechanisms remain unclear between them. Here, we postulate that RI might regulate ILK signaling
pathway via interacting with ILK.
Methods: Co-immunoprecipitation, GST pull-down and co-localization under laser confocal microscope assay
were used to determine the interaction between ILK and RI exogenously and endogenously. Furthermore, we
further verified that there is a direct binding between the two proteins by fluorescence resonance energy
transfer (FRET) in cells. Next, The effects of interplay between ILK and RI on the key target protein expressions
of PI3K/AKT/mTOR signaling pathway were determined by western blot, immunohistochemistry and
immunofluorescence assay in vivo and in vitro. Finally, the interaction was assessed using nude mice
xenograft model.
Results: We first found that ILK could combine with RI both in vivo and in vitro by GST pull-down,
co-immunoprecipitation (Co-IP) and FRET. The protein levels of ILK and RI revealed a significant inverse
correlation in vivo and in vitro. Subsequently, The results showed that up-regulating ILK could increase cell
proliferation, change cell morphology and regulate cell cycle. We also demonstrated that the overexpression
of ILK remarkably promoted EMT and expressions of target molecules of ILK signaling pathways in vitro and
in vivo. Finally, we found that ILK overexpression significantly enhanced growth, metastasis and angiogenesis
of xenograft tumor; Whereas, RI has a contrary role compared to ILK in vivo and in vitro.
Conclusions: Our findings, for the first time, directly proved that the interplay between ILK and RI regulated
EMT via ILK/PI3K/AKT signaling pathways for bladder cancer, which highlights the possibilities that ILK/RI
could be valuable markers together for the therapy and diagnosis of human carcinoma of urinary bladder.
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Background
Integrin-linked kinase (ILK), a 59 kDa serine/threonine
kinase, was discovered by detecting its interactions with
the β1 integrin subunit [1]. ILK regulates a plethora of
biological processes such as cell cycle, growth and angio-
genesis; high expression of ILK enhances tumorigenesis
[2, 3]. ILK directly phosphorylates AKT and GSK-3β to
mediate β-catenin for oncogenesis [4]. Over-expression
of ILK has a close relationship with prostate cancer,
high-grade gastric cancer, and NSCLC (non-small cell
lung cancer) [5–7]. In addition, it has been reported that
increased expression of the protein is inversely related to
the 5-year survival rate in prostate cancer [6]. ILK has
important functions in promoting epithelial to mesenchy-
mal transition (EMT) in mammary epithelium and the
tumor invasion with a lower expression of E-cadherin
[8, 9]. Using a selective inhibitor of ILK has been
demonstrated to induce E-cadherin expression [10].
This is supposed to be an effective way to inhibit
EMT [11]. However, the molecular basis for the high
level expression and regulatory mechanism of ILK re-
main unclear in tumor.
Ribonuclease A (RNase A), a member of superfamily,
has strong catalytic capability to the hydrolysis of RNA.
When the protein reaches an optimal level, it might act
as a passage of genetic information from DNA to protein
via RNA. However, the protein at a higher concentration
causes cell damage by resisting protein synthesis through
increased ribonucleolytic activity. And this phenomenon
aroused great interest of scientists in designing ribo-
nuclease inhibitors [12–14]. Ribonuclease inhibitor (RI)
is a 50 kDa horseshoe-shaped protein. It functions as the
inhibitor of the ribonucleolytic activity of RNase A and
angiogenin via a close interaction with them [15–18]. RI,
also termed angiogenin inhibor or RNH1, is abundant in
the cell cytosol and also exits in mitochondria and nuclei
[19]. The capacity of RI to protect genome integrity and
cell viability from oxidized stress damage has been docu-
mented, and corresponds with the sensitivity to oxida-
tion and the role of the protein in reactive oxygen
species (ROS) scavenger in vitro [20–22]. RI, made up of
15 leucine-rich repeats (LRRs), emerges as a core protein
in the research of LRRs. Its unique structure and func-
tion suggested that it could have a significant role in
protein-protein interaction [23]. Therefore, we suppose
that unknown biological functions exist in RI.
Human ILK gene and RNH1 gene both located at
chromosome 11p15. In chromosome 3 of Drosophila,
chromosome 7 of mice, chromosome 1 of rat and
chromosome 11 of human, RI and ILK are always neigh-
boring in the same chromosome. Depending on the
chromosome proximity method, if the neighborship of
two genes is conserved in different genomes during
revolution, they may have some related functions [24].
We have reported that ILK and RI had a co-localization
and are negatively correlated in the EJ cells [25]. Our
previous experiments also showed that RI down-
regulated ILK and suppressed the phosphorylation of
PKB/Akt and GSK-3β [26]. Therefore, these data suggest
the possibility of the interaction between the two proteins.
However, it’s unclear whether RI can directly bind to ILK.
Furthermore, mechanism underlying the interaction be-
tween the two proteins has not been reported so far.
This research is aimed at further revealing the molecu-
lar mechanisms of interplay between ILK and RI as well
as supplying new methods to the therapy of carcinoma
of bladder. Here, we report that ILK could combine with
RI to regulate its biological function in vivo and in vitro.
This research first proved that direct binding of RI and
ILK regulated EMT through ILK signaling pathway in
bladder cancer. Our study may provide novel prognostic
and therapeutic targets for bladder cancer.
Methods
Cell lines, animal and reagents
EJ cells, HEK 293 cells, pcDNA3.1(−)-myc-RI, pGEX-
4 T-RI and pEGFP-C1-RI plasmids were conserved and
prepared by our laboratory. pGEX-4 T-1 was bought
from GE Healthcare China. pEYFP-N1vector was from
Clontech. pCMV-3xflag-CMVTM-10 was purchased
from Sigma. BALB/C nude (nu/nu) mice were obtained
from Beijing HFK Bioscience Company (Beijing, PR
China). FBS was from TBD Science (Tianjin, PR, China).
DMEM/High glucose medium, RPMI 1640 medium and
G418 were purchased from Gibco-BRL (Carlsbad, CA,
USA). Lipofectamine 2000 was bought from Invitrogen,
Inc., (Carlsbad, California). Monoclonal mouse antibody
of anti-human ILK was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Rabbit anti-
human β-actin, CD31 antibody, Monoclonal primary
rabbit antibody of anti-human PI3K, p-PI3K, PTEN,
p- PTEN, Akt, p-Akt, GSK3β, p-GSK3β, mTOR, p-mTOR
and β-catenin were obtained from Bioworld Technology,
Inc. (St. Louis, USA). The rest of the primary anti-
bodies are from Proteintech Group, Inc (Chicago, IL,
USA). Cell Counting Kit-8 was bought from Genview
Scientific, Inc (Craigieburn, VIC, AUS).
Construction of the plasmids
Human ILK cDNA sequence (accession number:
NM_004517) was provided by the GenBank. The
pEYFP-ILK and pCMV-3 × Flag-ILK plasmids were
constructed through the application of recombinant-DNA
technology. The design for pEYFP-N1 plasmid (Clontech)
primers was as follows: forward, 5′-CCGCTCGAGGCT
ATGGACGACATTTTCAC-3′, and reverse, 5′- CGGA
ATTCTCTTGTCCTGCATCTTCTCA -3′; The primers
for pCMV-3xflag-CMV™-10 plasmid (Sigma) is following:
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forward, 5′- CCCAAGCTTATGGACGACATTTTCACT
C -3′, and reverse, 5′- GCTCTAGACTACTTGTCCTGC
ATCTTC -3′. The recombinant plasmids pEYFP-N1-ILK
was identified by using restriction enzymes Xho I and
EcoR I (underlined), and the pCMV-3 × Flag-ILK was
identified by using restriction enzymes Hind III and
Xba I (Italic). Finally, all plasmids were sequenced
and then using BLAST software to verify the
sequences.
Cell culture and establishment of stable cell lines
The EJ cells were cultured in RPMI 1640 media with
10 % FBS in a culture chamber containing 5 % CO2 at
37 °C. The cells were collected and then inoculated into
six well plates. Calcultate the growth rate of the cells
and enable them to grow until 80–90 % of the conflu-
ence on the next day. The cells were immediately trans-
fected with the plasmids by Lipofectamine 2000. After
2 days, the choice was executed with 800 μg/ml of G418
for 2 weeks and 400 μg/ml of G418 for another 2 weeks.
Finally, we selected the positive clones, and then prolif-
erated stable cell lines that express ILK and the blank
control vector which named EJ-ILK and EJ-FLAG cell
respectively. Recombinant lentivirus containing RI
(LV-RI) and control (LV-NC) were purchased from
Western Biotechnology (Chongqing, PR, China). In
order to establish the stable cell line, 2 × 105 EJ cells
were transfected with 4 × 106 transducing units of len-
tiviruses, the supernatant was removed after 24 h and
replaced with complete culture medium. After that,
the EJ cells were selected with 2 μg/ml puromycin for
two weeks. The two kinds of stable cell lines were
named EJ-RI and EJ-LV5, respectively. HEK 293 cells
were cultivated in DMEM/High glucose medium with
10 % FBS at 37 °C.
Western blot analysis
Immunoblot analysis was performed as following.
Briefly, total cell protein lysates were obtained with
RIPA buffer containing proteinase inhibitor (Sigma,
St. Louis, MO, USA). The proteinof 30 μg was sepa-
rated by appropriate concentration of SDS PAGE
and shifted to PVDF membranes, then blocked, the
membranes were incubated overnight with primary
antibodies of AKT, p-AKT, GSK3β, p-GSK3β, PI3K,
p-PI3K, PTEN, p-PTEN, mTOR, p-mTOR, β-catenin,
E-cadherin, MMP2, MMP9, N-cadherin, Vimentin,
Twist, Snail, S100A4, Smad2 and β-actinat at 4 °C.
Next, washed with TBST, incubated with species-
specific secondary antibodies labeled with HRP at
37 °C for 2 h and visualized with an ECL chemilumines-
cent detection system (Thermo Scientific). Loading differ-
ences were normalized using a monoclonal β-actin
antibody.
GST pull down
The encoded RI-GST fusion proteins and the control
GST proteins were expressed in BL21 cells after induc-
tion with IPTG. The GST-fusion proteins were arrested
by glutathione–Sepharose 4B beads (GE Healthcare,
Little Chalfont, UK) for the GST pulldown assays, and
Flag-ILK (transfected EJ cells or HEK293 cells extracts)
was added. Binding was performed for 3 h under rota-
tion at 4 °C and the beads were washed with ice-cold
PBS. The supernatant was loaded to gels followed by
Western blot identification.
Co-immunoprecipitation assay (Co-IP)
For co-immunoprecipitation, EJ cells and HEK 293
cells were co-transfected with pCMV-3 × Flag-ILK and
pcDNA3.1(−)-myc-RI using Lipofectamine 2000 re-
agent (Invitrogen). Cells were trypsinized and rinsed
in PBS. The protein extracts were then incubated
using anti-Myc antibody and precipitated with protein
A-agarose (Invitrogen). The precipitated proteins were
separated and detected with Western blot using anti-
RI or anti-ILK antibodies. Finally, the blots were visu-
alized using ECL system (Amersham Biosciences).
Confocal microscope scanning and fluorescent resonance
energy transfer (FRET) assay
To visualize interaction of ILK and RI in EJ cells, FRET
imaging was conducted using cy3-conjugated goat anti-
rabbit IgG and Alexa Fluor 488- conjugated goat anti-
mouse IgG as biosensors. EJ cells were transfected with
pCMV-3 × Flag-ILK and pcDNA3.1(−)-myc-RI. And then
conventional immunofluorescent assay was performed.
Images of 488-ILK and cy3-RI FRET activities were ac-
quired using a Leica confocal imaging spectrophotometer
system (TCS-SP, Germany). Briefly, the fluorescence im-
ages for 488-ILK and cy3-RI were collected repetitively at
a 10 s interval for five times. After that, cy3 was
photobleached with full power of 543 nm line laser.
The emission intensities of 488-ILK and cy3-RI were
monitered and recorded. The FRET efficiency (FRETe) was
determined by computing the percentage of the 488-ILK
fluorescence recovery [FRETe = (488-ILKA −488-ILKB)/
488-ILKA× 100 %], where 488-ILKA was the 488 intensity
after photobleaching and 488-ILKB was the 488 intensity
before photobleaching of cy3.
Co-colonization detection and immunocytofluorescence
EJ cells and 293 cells were co-transfected with pla-
mids pEYFP-N1-ILK and pEGFP-C1-RI using lipofec-
tion. The fluorescence proteins were visualized with
Olympus multifunction microscope (Tokyo, Japan)
equipped with appropriate filters (Chroma). Finally,
images were captured and processed. The other way
to detect location: EJ cells were co-transfected with
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plasmids pCMV-3 × Flag-ILK and pcDNA3.1(−)-myc-
RI. After that, cells were fixed by 4 % paraformalde-
hyde, then permeabilized by Triton X-100. For detec-
tion of co-location, an antibody mix containing ILK
(Santa Cruz, CA, USA) and RI was used. In co-
immunostainings, goat anti-rabbit conjugated Alexa
594 and goat anti-mouse conjugated Alexa 488 were
used and nuclei was stained with DAPI. Observations
were performed and pictures were taken under Laser
Scanning Confocal Microscope. For conventional IF
assays, cells were incubated overnight at 4 °C in pri-
mary antibodies against ILK (Santa Cruz, CA, USA)
and RI separately. And the IF was performed as de-
scribed above.
Cell morphology, cell cycle and cell growth
The cells were grown on cover glass in 6-well plates,
washed with PBS. The pictures of cells were taken under
phase contrast inverted microscope (NIKON TE2000-U,
Japan). For cell cycle assay, cells were trypsinized,
washed by PBS, and then resuspended with 70 % ethanol
and incubated on ice for 24 h. The distribution of cell
cycle phase was assayed by flowcytometry (Becton
Dickinson FACSCalibur, USA). Cell proliferation rate
was determined by CCK-8 assay. Briefly, cells were
seeded in 96-well plates. The cell proliferation was mon-
itored every 24 h by CCK-8 assay. The medium were re-
placed with fresh medium containing 10 % CCK-8,
shake the plates gently and then incubate them in 37 °C
for 3.5 h. The absorbance value was detected by a plate
reader at 450 nm. ALL of the assays above were repeated
3 times.
Mouse xenograft models, histology, immunohistochemistry
and immunofluorescence
BALB/C nude mice used in these investigations were
handled in accordance with the Guide for the Care and
Use of Laboratory Animals (National Research Council,
1996). The animal production license and animal license
of Chongqing Medical University are SCXK (Beijing)
2014–0004, SCXK (Chongqing) 2007–0001. The stable–
transfected EJ cell lines (5 × 106) mixed with 1 × PBS
were injected into the flank of nude mice (4-week-old)
subcutaneously. Tumors and lungs were harvested
30 days after injection, the tumor tissue was weighed.
The 4 μm tumor tissue sections were stained by HE
(hematoxylin-eosin) and microvessels were numbered.
The 5-μm-thick adhesion slides were dewaxed and then
immersed in a gradient alcohol and washed three times.
They were treated with 0.3 % H2O2 and then subjected
to 10 % sheep serum for 30 min. The slides were incubated
overnight with primary antibodies of RI, ILK, p-AKT, p-
GSK3β, p-mTOR, β-catenin, E-cadherin, MMP2, MMP9
and Vimentin. The next day, slides were incubated with
secondary antibodies of Anti-mouse and rabbit IgG for 1 h
and then immersed in avidin biotin-peroxidase complex
diluted in PBS and visualized with amino-ethyl carbazole
chromogen stock solution. For IF, 10-μm-thick frozen
tumor sections were fixed in acetone, blocked, and
incubated overnight at 4 °C in primary antibodies
against p-AKT, p-GSK3β, p-PI3K, p-PTEN, p-mTOR,
β-catenin, E-cadherin, MMP2, MMP9, Vimentin, S100A4
and CD31. The next day, sections were incubated with
fluorescein 594 and 488-conjugated secondary antibodies.
Images were obtained using Olympus multifunction
microscope (Tokyo, Japan).
Analysis of ILK and RI expression in tumor tissue from
nude mice and human bladder cancer samples
Bladder carcinoma and corresponding non-tumor nor-
mal tissues were obtained from the first clinical college
of Chongqing Medical University. All samples were de-
identified. The 10-μm-thick frozen tumor tissue sections
were fixed with acetone, blocked, and incubated over-
night at 4 °C in primary antibodies against ILK and RI.
As described above, HE staining and IF assay were
conducted.
Statistical analysis
Data were processed with SPSS19.0 statistical software.
The values were expressed as means ± SD. Student’s t
tests were used for statistical analysis. P values of less
than 0.05 were considered to be statistically significant.
Results
Over-expression of ILK and RI is identified
ILK gene sequence and vector were verified correctly by
enzyme digestion, sequence analysis (data not shown).
The transfected cells were selected, and then cloned,
proliferated, finally verified by Western Blot and
immuno-fluorescence assay. The expression of RI pro-
tein levels was significantly heightened in EJ-RI cells,
compared with the other two control group cells re-
spectively. The expression of ILK was observably in-
creased in EJ-ILK cells, compared with the control
group cells respectively (Fig. 1a). Immunofluorescence
assay revealed that RI and ILK were brighter in EJ-RI
and EJ-ILK cells respectively, compared with the corre-
sponding control cells (Fig. 1b and c). The results dem-
onstrated that RI or ILK were steadily expressed in the
cells respectively.
ILK binds to RI in vivo and in vitro
To determine whether there is a direct interaction be-
tween ILK and RI, in vitro pull-down experiments were
conducted. GST-RI constructs were used in pull-down
assays with plasmids pCMV-3 × flag-ILK. Western blot
proved that ILK protein from EJ cells (Fig. 2a) and 293
Zhuang et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:130 Page 4 of 14
cells (Fig. 2b) transfected pCMV-3 × flag-ILK and en-
dogenous ILK could be captured by GST-RI and be
pulled down specifically, demonstrating a physical bind-
ing of RI and ILK in vitro.
To further investigate the interplay of RI and ILK,
we executed co-immunoprecipitation detection. RI
and ILK were explored in immunoprecipitation com-
plex with anti-myc antibodies. The results demon-
strated that ILK and RI could have a binding and
interaction (Fig. 2c and d).
Fluorescent resonance energy transfer and colocalization
of ILK with RI are identified
To further detect real-time dynamic ILK-RI interaction
in the living cell physiological conditions, we then ap-
plied FRET technology. As shown in the Fig. 3a, b, c and
e, the FRET appeared between ILK and RI in EJ cells,
which further confirmed the interaction between ILK
and RI in living cells.
To investigate whether RI and ILK would localize in
the same site of live cells for functional partners, we
used vectors of GFP-RI fusion proteins and YFP-ILK fu-
sion proteins. The subcellular localization of exogenous
ILK and RI was observed in 293 and EJ cells under im-
munofluorescence microscopy. RI was green while ILK
was red in both 293 cells and EJ cells. Then, we acquired
the yellow merge figures (Fig. 3f ). Furthermore, we per-
formed IF assay to detect the localization. The immuno-
fluorescence revealed that most of ILK distributed in
cytoplasm (green). We also observed that RI was mainly
spread in the cytoplasm (red). As a result, the yellow
area which demonstrated that co-localization of ILK
with RI existed in the cytoplasm (Fig. 3g).
Up-regulating RI or ILK affects cell morphology, cell cycle
and proliferation
Live cells images showed that EJ-ILK cells became mes-
enchymal morphology and higher malignant phenotypes
such as a larger nucleus and more division phases com-
pared with other two control groups. Whereas, the cells
in EJ-RI group revealed epithelial features and lower de-
gree of malignant morphology (Fig. 4a).
The cell cycle was detected by flow cytometry. The
graph displayed that the percentage of EJ-RI cells was in-
creased by 71.24 % ± 6.89 % and 63.26 % ± 7.71 % in the
S phase as well as it was decreased by 36.18 % ± 4.26 %
and 35.82 % ± 3.66 % in the G1 phase, compared with
the EJ cells and EJ-LV5 cell group, respectively. Meanwhile,
the percentage of EJ-ILK cells was increased by 10.73 % ±
1.10 % and 10.41 % ± 1.70 % in the G1 as well as it was
Fig. 1 ILK and RI expression is determined by Western blot and Immunofluorescence after transfection for 48 h. a Immunofluorescent
observation of ILK and RI was detected respectively. EJ-ILK cells demonstrated remarkably stronger immunofluorescent signal in cytoplasm
whereas EJ-RI cells demonstrated significantly stronger immunofluorescent signal in nucleus, compared with the other control groups
respectively (magnification × 200). b & c ILK and RI protein expression level was evaluated by Western blot. Proteins were separated by
SDS-PAGE and then binded to specified monoclonal ILK antibodies or polyclonal RI antibodies. β-actin was used as control. The levels of
ILK proteins were remarkably increased by transfected with pCMV-3 × FLAG-ILK and the levels of RI proteins were significantly increased
by transfected with lentivirus containing RNH1 (LV-RNH1), compared with the control groups respectively
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decreased by 72.58 % ± 6.23 % and 70.08 % ± 10.40 % in
the G2/M phase, compared with the EJ cells and EJ-FLAG
cell group, respectively. However the EJ-RI in G2/M phase
and EJ-ILK in S phase did not show significantly different.
The results above showed that the growth of EJ-RI cells
was prohibited with G1 phase decreasing and S phase ar-
resting while ILK induced G2/M phase reducing and G1
phase increasing in the EJ cells (Fig. 4b and c).
The 450 nm absorbance is in accordance with the num-
ber of living cells. The Inhibition rates of EJ-RI cells to EJ
vector cells, and the promoting rates of EJ-ILK to EJ vector
cells were 29.41 and 35.29 % at 120 h respectively.
Whereas, the growth of the control cells was not be af-
fected, *P < 0.05. The A450 was observably decreased with
CCK8 in the EJ-RI cells. The EJ-RI cells demonstrated
lower cell proliferations than those of the EJ cells and the
EJ-LV5 cells. As for EJ-ILK cells, the A450 was significantly
increased with CCK8, compared with EJ cells and EJ-
FLAG cells (Fig. 4d). According to the data, the reproduct-
ive capacity of the EJ-ILK cells strengthened obviously.
Up-regulating RI or ILK affects the expressions of proteins
associated with ILK signaling pathways and EMT
To futher investigate the molecular mechanism of RI
and ILK in cell metastasis, we detected protein levels of
theimportant target molecules of ILK pathway and EMT
with Western blot. The expressions of AKT, GSK3β,
PI3K and mTOR and did not significantly change. But,
the levels of p-Akt, p-GSK3β, p-PI3K, p-PTEN, p-
mTOR and β-catenin were increased markedly in EJ-ILK
cells whereas these protein levels decreased obviously in
EJ-RI cells (*P < 0.05). MMP2, MMP9, N-cadherin,
Vimentin, Twist, Snail and S100A4 were increased sig-
nificantly in EJ-ILK cells whereas these protein levels de-
creased obviously in EJ-RI cells, compared with control
group cells respectively (*P < 0.05). Furthermore, PTEN,
E-cadherin and Smad2 expressions were obviously in-
creased in the EJ-RI cells group, whereas these protein
levels were down-regulated in the EJ-ILK cells group,
compared with control groups respectively (Fig. 5a, b, c
and d). Results show that the RI increase might be re-
lated with inhibition of the ILK signaling pathways and
EMT. While, up-regulating ILK promoted ILK signaling
pathways and EMT.
Up-regulating RI or ILK affects tumor growth and
experimental lung metastasis of BALB/C nude mice
To further study to the effects of the RI and ILK on
tumor growth respectively, 5 × 105 various kinds EJ cells
were inoculated subcutaneously into nude mice. HE
staining and IF assay were conducted to further verify
the influence of RI and ILK on tumor growth and
Fig. 2 RI interacts with ILK in vivo and in vitro. The interaction of RI with ILK was detected as described in “Materials and methods” with GST
pulldown and co-immunoprecipitation (Co-IP). a & b The interaction of RI with ILK was determined by GST pull down. The bacteria were induced
with 0.1 mmol/L IPTG in different time, and then the fusion protein was obtained after ultrasonic decomposition and washed repeatedly. Western
blot showed that ILK protein from EJ cells (a) or 293 cells (b) transfected with pCMV-3 × flag-ILK and pCMV-3 × flag could be combined with
GST-RI and be specifically pulled down. c & d RI was co-immunoprecipitated with ILK in EJ cells (c) or 293 cells (d). The interaction of RI with ILK
was detected as described in Methods, the co-immunoprecipitation of RI and ILK suggested that ILK could specifically bind to RI in the cells
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Fig. 3 (See legend on next page.)
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metastasis. The rates of tumor formation were signifi-
cantly lower in EJ-RI group compared with the other
two control group cells, respectively. The rates of inhibi-
tory tumors were 54.54 and 60.11 % compared with the
EJ-LV5 and EJ cells groups. The tumors in the EJ-ILK
cells groups were heavier than those in the other two
control groups. The promoting rates of tumors were
222.22 and 200.94 % compared with the EJ-FLAG and
EJ cells groups, respectively, *P < 0.05 (Fig. 6a and b).
The results showed that the ILK significantly facilitated
the growth of bladder cancer, whereas, RI obviously sup-
pressed xenograft tumor. The mice injected with EJ-RI
cells displayed an obvious suppression of the metastasis
with a substantial reduction of invasive tumor cells.
Mice injected with EJ-ILK cell groups showed a remark-
able increase of pulmonary metastatic nodules, com-
pared with EJ and EJ-FLAG cells group (Fig. 6c).
Microvessels of 5 different fields were counted under
Fig. 4 Cell morphology, cell cycle and cell proliferation are observed. a The observation of living cell was executed (magnification × 200). The
EJ-ILK group’s cells showed mesenchymal a characteristic and more division phases compared with some cells in the other control groups. On
the contrary, EJ-RI cells displayed an epithelial morphology and less division phases compared with some cells in the other control groups. b Flow
cytometry was conducted with propidium iodide staining. Experiments were repeated three times, samples were analyzed by Student’s T-test and
statistical significance with *P < 0.05. c Flow cytometry analysis of cell cycle distribution demonstrated that the percentages of the EJ-RI cells in S
phase were significantly increased, whereas the percentages of EJ-RI cells in G1 phase were decreased in comparison to EJ cells or EJ-LV5 cells. In
addition, a slight increase in G1 phase and a decrease in G2/M phase were detected in EJ-ILK cells. d 1.5 × 103 cells were added into a 96 well
plate, the CCK8 assay was performed and recorded the A450 with a plate reader every 24 h. Each point represents the mean of twelve independent
samples and experiments were repeated 3 times. EJ-RI cells showed inhibited proliferation abilities, whereas increased proliferation abilities were
detected in EJ-ILK cells, compared with control group cells respectively, *P < 0.05
(See figure on previous page.)
Fig. 3 Fluorescent resonance energy transfer and colocalization of ILK with RI are assayed. a-d EJ cells were co-transfected with plasmids as
described previously, and then followed by photobleaching analysis. Images indicated the 488 and cy3 fluorescence emission intensities in the
cells before and after photobleaching. e The FRET efficiency (FRETE) was calculated as the percentage of the 488 fluorescence recovery. The
experiments were repeated 3 times. f The Intracellular localizations observation of RI and ILK. EJ cells and 293 cells were co-transfected with
plamids pEYFP-N1-ILK and pEGFP-C1-RI. The two Proteins labeled with fluorescent proteins revealed a colocalization under Olympus multifunction
microscope. g RI expression and colocalization experiment also were observed under laser scanning confocal microscope. Immunofluorescence
staining of RI (red) and ILK (green) in four groups of EJ cells co-transfected with different pairs of plasmids. The nucleus was stained with DAPI
(blue). The yellow part demonstrated that ILK colocalized with RI in EJ cells. The expression of RI markedly decreased in ILK-upregulated cells
compared with the control group cells (magnification × 200)
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microscope with the HE sections of tumor. EJ-ILK
cells reaveled more tumor microvessels compared
with the control groups, whereas EJ-RI groups indi-
cated fewer microvessels compared with the controls
(*P < 0.05) (Fig. 6d and e). Immunofluorescent ana-
lyses of CD31 and S100A4 were conducted. Results
displayed that the EJ-ILK cells group had a higher
CD31 and S100A4 expression and apparent increase
of angiogenesis; whereas weaker CD31 and S100A4
expression and fewer microvessels were observed in
the EJ-RI groups (Fig. 6f ).
Up-regulating RI or ILK affect the expressions of proteins
associated with ILK signaling target molecules and EMT in
tumor tissue
Immunohistochemical and immunofluorescent detections
were conducted to determine the impacts of ILK and RI
expression on ILK signaling pathways and EMT in tumors
respectively. The results revealed that EJ-ILK cells group
showed much lower RI and E-cadherin levels as well as
stronger positive signal of ILK, p-Akt, p-GSK3β, p-PI3K,
p-PTEN, p-mTOR, β-catenin, MMP2, MMP9 and Vimen-
tin in tumor tissue, whereas lower ILK, p-Akt, p-GSK3β,
p-PI3K, p-PTEN, p-mTOR, β-catenin, MMP2, MMP9
and Vimentin expression were observed in tumor tissue of
the EJ-RI groups (Fig. 7). These results were consistent
with analysis in vitro, suggesting that the interaction be-
tween RI and ILK could be related with regulation of ILK
signaling pathway and EMT.
High ILK and low RI protein levels are observed in tumor
tissue of nude mice and human bladder cancer
To gain insights into the expression of ILK and RI in
tumor tissue from nude mice and human bladder cancer,
Fig. 5 Up-regulating RI and ILK regulates the expression of ILK signaling pathway molecules and proteins associated with EMT in vitro. The total
protein of cells was collected using cell lysis buffer, the expressions of ILK signaling pathway molecules and proteins associated with EMT were
examined using corresponding antibodies by immunoblot analysis. β-actin was served as the control. Relative protein levels were normalized
against those of β-actin by MJ Opticon Monitor Analysis Software (Bio-Rad). Data were calculated as means ± S.D (n = 3). *P < 0.05. a & b The
results demonstrated that transfections with pCMV-3 × FLAG-ILK in EJ cells significantly up-regulated the expressions of p-Akt (S473), p-GSK3β (S9),
p-PI3K, p-PTEN, p-mTOR and β-catenin, compared with control groups respectively, whereas these protein levels decreased obviously in EJ-RI cells.
The protein expressions of AKT, PI3K, mTOR and GSK3β did not change apparently, compared with control groups respectively. c & d Western
blot assay and semi-quantitative analysis showed that protein levels of MMP-2, MMP-9, N-cadherin, Snail, Twist and Vimentin were decreased,
while protein levels of E-cadherin and Smad2 were significantly increased in EJ-RI cells compared with the control groups respectively. E-cadherin
was significantly weaker in the EJ-ILK cells group compared with the other control groups and MMP-2, MMP-9, N-cadherin, Snail, Twist, S100A4
and Vimentin were increased in EJ-ILK cells groups
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we performed immunofluorescent assay to determine
the two kinds of protein level in the specimens. The data
suggest that ILK expression was negatively correlated
with RI levels in the bladder cancer specimens from
nude mice and human. Human tumor and nude mice
xenograft tumor tissues showed the expression of ILK
was increased while the expression of RI was inhibited
(Fig. 8a and b). The fact that higher level of RI and lower
level of ILK in paired normal tissues suggest that RI
could be required to regulate ILK for suppression of
bladder cancer.
Discussion
Invasive or metastatic bladder cancer is a lethal disease
in spite of surgery, radiation treatment and chemother-
apy. Unfortunately, transurethral resection or other adju-
vant treatments do not achieve much in preventing
tumor metastasis and recurrence. Finally, 20–30 % of
those tumors progress into more aggressive tumors and
cause death of patients [27, 28].
Protein-protein interaction plays a critical role in every
essential biological process. Human ribonuclease inhibi-
tor (RI) contains 15 Leucine-rich repeats (LRRs). Such
repeats have been considered to have multiple functions,
such as extracellular matrix interaction, cell-cycle regula-
tion, DNA repair and enzyme inhibition [17]. Therefore,
we speculate that RI might still have some undiscovered
biological roles. Our previous study showed that ILK and
RI have a common subcellular location, and the expres-
sion of RI was negatively correlated with ILK in BIU-87
cells [29]. Yet, correlation between RI and ILK has not
been fully understood. ILK plays an important role in
transducting many of the biochemical signals that are
triggered by cell-matrix interactions and modulate
Fig. 6 Up-regulating RI and ILK modulates tumor growth and spontaneous lung metastasis of BALB/C nude mouse xenograft model. 5 ×
106tumor cells including the EJ-RI cells, the EJ-ILK cells, EJ-LV5 cells, EJ-FLAG and EJ cells were respectively injected subcutaneously into
the flanks of the BALB/C nude mice. After 4 weeks, the mice were ultimatedly killed. The tumors and lungs were collected, weighed, and
photographed. a Representative images of the xenograft tumors and the BALB/C nude mice after removing tumors. b Tumor weight
analysis. The EJ-ILK cell groups remarkably promoted the growth of xenograft tumor compared with the control groups, whereas EJ-RI
cells groups inhibited the growth of xenograft tumor, compared with the other control groups. c HE staining of lung sections, arrows
show invasive tumor cells in lung. (magnification 200×). d HE staining of tumor sections, arrows indicates microvessels among xenograft tumors
(magnification 200×). e Microvessel density analysis. f Immunofluorescent staining with antibodies against CD31 and S100A4 of vascular endothelial
cells. Immunofluorescent and histochemical study demonstrated that large amounts of microvessels could be detect in the tumors of the mice
injected with EJ-ILK cells. By comparison, there were fewer microvessels in the tumor of the mice injected with EJ-RI vector cells (magnification × 200)
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fundamental processes such as growth, survival, differenti-
ation, invasion and angiogenesis. In vertebrates, loss-of-
function analyses have highlighted the importance of ILK
in the regulation of protein-protein interactions that are
related to the activation of signaling pathways. The further
study of ILK will emphasize on its function of the direct
and indirect interactions existing in ILK. Which inter-
action is more important for normal tissue depends on
which interaction is more crucial for the development of
human malignant tumors. As a matter of fact, if ILK could
be effectively targeted, the upper proposition will be
proved and valued properly [30–32]. However, it is un-
known whether there is also an interaction between ILK
and RI in cancer progression and the mutual relationship
has remained unclear so far.
Here, we first reported that RI and ILK have a physical
interaction between them, and we use colocalization
analysis, co-immunoprecipitation and pull-down assays
to prove the hypothesis. We also found for the first time
that RI could suppress ILK activity by extremely tight
combination in vitro. RI contains leucine-rich repeats
(LRRs), which have vast surface areas to supply protein
interaction [23].
In this study, we also showed that ILK could promote
the cell proliferation, change cell morphology and regu-
late cell cycle. Meanwhile, we demonstrated that over-
expression RI decreased the proliferation and led to cell
cycle arrest in S phase. Moreover, we also showed that
over-expression of ILK remarkably promotes the phos-
phorylation of signaling targets AKT, GSK-3β, PI3K and
Fig. 7 Up-regulating RI and ILK regulates the expressions of ILK signaling pathway molecules and EMT-related proteins in vivo. a Immunofluorescent
sections were stained in tumor xenograft tissue with rabbit anti-human p-Akt (S473), p-GSK3β (S9) p-PI3K, p-PTEN, p-mTOR, β-catenin, E-cadherin,
MMP2, MMP9 and Vimentin respectively, then were incubated with Alexa Fluor 594 Goat Anti-Rabbit IgG or Alexa Fluor 488 Goat Anti-Rabbit IgG
secondary antibody. EJ-ILK cell groups resulted in significantly higher p-Akt, p-GSK3β, p-PI3K, p-PTEN, p-mTOR, β-catenin, MMP2, MMP9 and Vimentin
as well as lower E-cadherin expressions in tumor tissue, compared with EJ and EJ-FLAG cells groups. In contrast, weaker p-Akt, p-GSK3β, p-PI3K, p-PTEN,
p-mTOR, β-catenin, MMP2, MMP9 and Vimentin expression were detected in tumor tissue of the EJ-RI cell groups along with stronger E-cadherin
expressions, which was in accordance with experiments in vitro (magnification × 200). b Immunohistochemical sections stained with
mouse anti-human ILK, rabbit anti-human RI, p-Akt(S473), p-GSK3β(S9), p-mTOR, β-catenin, E-cadherin, MMP2, MMP9 and Vimentin
respectively, the nuclei were counterstained by hematoxylin (magnification 400×). Representative images demonstrated that the EJ-RI cell
groups had a weaker brown immunostain for ILK, p-Akt, p-GSK3β, p-mTOR, β-catenin, MMP2, MMP9 and Vimentin as well as a stronger
positive signal for RI and E-cadherin in cytoplasm compared with the control group cells respectively. EJ-ILK cells group revealed much
lower RI and E-cadherin expressions as well as stronger positive signal of ILK, p-Akt, p-GSK3β, p-mTOR, β-catenin, MMP2, MMP9 and
Vimentin expressions in tumor tissue (magnification × 400)
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mTOR in vivo and vitro. ILK/AKT/mTOR signaling
pathway is widely known for modulating cell growth,
differentiation, apoptosis, cellular metabolism and can-
cer cell survival. ILK phosphorylated Akt to play an
important role in anti apoptosis through direct phos-
phorylation of downstream target protein; ILK also
phosphorylate GSK-3 to inhibit its activity, then make
the beta catenin dephosphorylate in the steady state.
The beta catenin is accumulated and activates LEF/Tcf
to promote transcription, which can enable the expres-
sion of AP-1 and prompt expression of CyclinD1 and
MMP-9 expression and so on. The changes could result
in proliferation, invasion and metastasis of tumor cells
[33–35]. Meanwhile, we also detected some crucial tar-
get molecules to assess whether that RI regulates ILK
signaling pathways is truly very efficient. The results re-
vealed that RI suppressed the expression of the ILK and
phosphorylation of PKB/Akt, GSK-3β and other import-
ant molecules in this signaling pathway. Moreover, the
results indicated that PTEN expressions were signifi-
cantly increased in EJ-RI cells, but phosphorylated PTEN
was up-regulating in EJ-ILK cells groups, compared with
control group cells respectively. PTEN was activated due
to decrease of phosphorylated PTEN level, and then
inhibited downstream AKT activation. The role of PTEN
is serving on a tumor suppressor gene by suppressing
Akt/PKB signaling pathway. The activity of ILK is
suppressed by phosphatases such as ILKAP and PTEN
[36], our results agree with this research.
To gain invasive capabilities, tumor cells go through a
morphology and physiology change such as EMT. The
invasion of cancer cells is remarkably affected by EMT
[33]. Firstly, we showed that up-regulating ILK leads to
the cell phenotype from epithelial to mesenchymal mor-
phological changes. Secondly, in this study, we showed
that ILK increase caused a decrease of E-cadherin as
epithelial cell marker and an ascent of Vimentin and
N-cadherin as mesenchymal markers, and enhanced
the expression of Snail and Twist as EMT inducer.
The most obvious change of EMT is the down-regulating
E-cadherin and the acquisition the expression of EMT
regulators such as Snail, Slug and Twist [37]. Thirdly, We
also showed that over-expression of ILK could increase
the protein level of MMP-2 and MMP-9. It has been re-
ported MMPs have something to do with EMT in cancer
progression [38]. our experiment results supported the
view that ILK is an important regulator of EMT [39]. Con-
versely, we demonstrated that RI affected the expressions
of these EMT-related proteins in EJ cells, the results
showed that over-expression of RI remarkably restrained
EMT of EJ cells, which is in line with previous report [40].
Finally, the animal model experiment demonstrated
that ILK significantly promoted growth and metastasis
of transplanted tumor; tumors of EJ-ILK cell group were
Fig. 8 Expressions of ILK and RI in tumor tissue from nude mice and human bladder cancer are detected. a Tumor tissues from nude mice were
stained with mouse anti-human ILK and rabbit anti-human RI antibodies separately. b HE staining of human bladder tissue sections were
conducted and photographs were taken under microscope (magnification × 400). Human bladder tumor tissue and adjacent normal
bladder tissue were incubated in the antibodies mixed with mouse anti-human ILK and rabbit anti-human RI antibodies. Bladder tumor
tissue from both nude mice and human showed higher ILK expression as well as lower RI expression, whereas the expressions of RI and
ILK in adjacent normal bladder tissue were just the opposite (magnification × 200)
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heavier and the microvascular density is higher than
those in the control groups. Direct down-regulation of
ILK caused a reduction of endothelial cell growth and
blood vessel formation in vivo [41]. Moreover, fewer me-
tastases of the lung were detected in the EJ-RI group;
and that, EJ-ILK cell groups showed a remarkable inva-
sion and metastases. In particular, we found the expres-
sion of S100A4 markedly enhanced in EJ-ILK cells
group compared other groups in vivo and vitro. S100A4
secreted by tumor and stromal cells, is a member of the
S100 calcium-binding protein family. It can support
tumorigenesis by triggering angiogenesis. Recently, S100A4
has attracted the attention of researchers because its ex-
pression is related to the movement, invasion, metastasis,
angiogenesis and prognosis of various tumors [42], which
agree well with our findings. Our study also proved that RI
inhibited ILK expression and suppressed angiogenesis both
in vivo and in vitro. Interestingly, our observation on the
human pathological specimens consistently revealed that
RI and ILK negatively correlated in tumor and non-tumor
tissues, which is corresponding to in vitro and animal
experiments.
Conclusions
Taken together, for the first time, our data demonstrated
that RI might regulate the function of ILK through mu-
tual binding. Therefore, we propose that RI could sup-
press tumorigenesis, EMT and metastasis by regulating
ILK mediated signal pathway. The data provided evi-
dence that ILK could be a valuable therapeutic and diag-
nostic target for bladder cancer. Our research also
highlights the possibilities that RI could serve as a prom-
ising anti tumor protein and angiogenesis inhibitor. Fur-
ther research will be required to verify the underlying
molecular mechanism of the interaction between ILK
and RI.
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